Diabetic Mouse Model of Orthopaedic Implant-Related Staphylococcus Aureus Infection

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Lovati, Arianna B ^a   Drago, Lorenzo ^b,c   Monti, Lorenzo ^b   De Vecchi, Elena ^b   Previdi, Sara ^d   Banfi, Giuseppe ^b,c   Romanò, Carlo L ^b  

^a IRCCS POLICLINICO SAN DONATO   (Italy)

^b IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIUM CULTURE; BIOFILM; BONE INFECTION; BONE INJURY; COLONY FORMING UNIT; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HISTOLOGY; IMMUNE RESPONSE; IN VIVO STUDY; LEUKOCYTE COUNT; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; ORTHOPEDIC IMPLANT; OSTEOMYELITIS; PROSTHESIS INFECTION; PROTEIN DETERMINATION; SCANNING ELECTRON MICROSCOPY; SOFT TISSUE INFECTION; STAPHYLOCOCCUS INFECTION;

ANALYSIS OF VARIANCE; ANIMALS; BIOFILMS; C-REACTIVE PROTEIN; COLONY COUNT, MICROBIAL; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; FEMUR; HOST-PATHOGEN INTERACTIONS; HUMANS; MICE; MICE, INBRED NOD; MICROSCOPY, ELECTRON, SCANNING; ORTHOPEDIC PROCEDURES; PROSTHESES AND IMPLANTS; PROSTHESIS-RELATED INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; X-RAY MICROTOMOGRAPHY;

ANIMALIA; BACTERIA (MICROORGANISMS); MUS; STAPHYLOCOCCUS AUREUS;

EID: 84879263236     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067628     Document Type: Article

References (60)

1. Antoci V, Adams CS, Hickok NJ, Shapiro IM, Parvizzi J, (2007) Vancomycin bound to Ti rods reduces periprosthetic infection. Clin Orthop Relat Res 461: 88-95.
2. Bozic KJ, Kurtz SM, Lau E, Ong K, Vail TP, et al. (2009) The epidemiology of revision total hip arthroplasty in the United States. J Bone Joint Surg Am 91: 128-133.
3. Urquhart DM, Hanna FS, Brennan SL, Wluka AE, Leder K, et al. (2009) Incidence and Risk Factors for Deep Surgical Site Infection After Primary Total Hip Arthroplasty: A Systematic Review. J Arthroplasty S0883-5403(09)00411-2; doi: 10.1016/j.arth.2009.08.011.
4. Giavaresi G, Borsari V, Fini M, Giardino R, Sambri V, Gaibani P, et al. (2008) Preliminary investigations on a new gentamicin and vancomycin-coated PMMA nail for the treatment of bone and intramedullary infections: an experimental study in the rabbit. J Orthop Res 26: 785-792.
5. Kurtz SM, Lau E, Schmier J, Ong KL, Zhao K, et al. (2008) Infection burden for hip and knee arthroplasty in the United States. J Arthroplasty 23: 984-991.
6. Deirmengian C, Greenbaum J, Lotke PA, Booth RE Jr, Lonner JH, (2003) Limited success with open debridement and retention of components in the treatment of acute Staphylococcus aureus infections after total knee arthroplasty. J Arthroplasty 18 (7): 22-26.
7. Romanò CL, Romanò D, Logoluso N, Meani E, (2010) Septic versus aseptic hip revision: how different? J Orthop Traumatol 11(3): 167-174 doi:10.1007/s10195-010-0106-y.
8. Le NN, Rose MB, Levinson H, Klitzman B, (2011) Implant Healing in Experimental Animal Models of Diabetes. Journal of Diabetes Science and Technology 5 (3): 605-618.
9. Boulton AJ, Kirsner RS, Vileikyte L. (2004) Clinical practice: neuropathic diabetic foot ulcers. N Engl J Med 351:48 -55.
10. Rich J, Lee JC, (2005) The Pathogenesis of Staphylococcus aureus Infection in the Diabetic NOD Mouse. Diabetes 54: 2904-2910.
11. Calvet HM, Yoshikawa TT, (2001) Infections in diabetes. Infect Dis Clin North Am 15(2): 407-421.
12. Peleg AY, Weerarathna T, McCarthy JS, Davis TME, (2007) Common infections in diabetes: pathogenesis, management and relationship to glycaemic control. Diabetes Metab Res Rev 23: 3-13.
13. Jämsen E, Nevalainen P, Eskelinen A, Huotari K, Kalliovalkama J, Moilanen T, (2012) Obesity, diabetes, and preoperative hyperglycemia as predictors of periprosthetic joint infection: a single-center analysis of 7181 primary hip and knee replacements for osteoarthritis. J Bone Joint Surg Am 18; 94(14): e101.
14. Viens NA, Hug KT, Marchant MH, Cook C, Vail TP, Bolognesi MP, (2012) Role of diabetes type in perioperative outcomes after hip and knee arthroplasty in the United States. J Surg Orthop Adv 21(4): 253-260.
15. Adeghate E, Schatter P, Dunn E, (2006) An update on the etiology and epidemiology of diabetes mellitus. Ann N Y Acad Sci1084: 1-29.
16. Habash M, Reid G, (1999) Microbial biofilms: their development and significance for medical device-related infections. J Clin Pharmacol 39: 887-898.
17. Fulkerson E, Valle CJ, Wise B, Walsh M, Preston C, et al. (2006) Antibiotic susceptibility of bacteria infecting total joint arthroplasty sites. J Bone Joint Surg Am 88: 1231-1237.
18. Romanò CL, Romanò D, Albisetti A, Meani E, (2012) Preformed antibiotic-loaded cement spacers for two-stage revision of infected total hip arthroplasty. Long-term results. Hip Int 22 (8): 46-53.
19. Sheagren JN (1997) Infections in immunocompromised patients. In The Staphylococci in Human Disease. Crossley KB, Archer GL, Eds. New York, Churchill Livingstone, pp.565-582.
20. Rees DA, Alcolado JC, (2005) Animal models of diabetes mellitus. Diabet Med 22(4): 359-370.
21. Follak N, Kloting I, Merk H, (2005) Influence of diabetic metabolic state on fracture healing in spontaneously diabetic rats. Diabetes Metab Res Rev 21(3): 288-296.
22. Li D, Gromov K, Soballe K, Puzas JE, O'Keefe RJ, Awad H, Drissi H, Schwarz EM, (2008) Quantitative mouse model of implant-associated osteomyelitis and the kinetics of microbial growth, osteolysis, and humoral immunity. J Orthop Res 26: 96-105.
23. Stoodley P, Ehrlich GD, Sedghizadeh PP, et al. (2011) Orthopaedic biofilm infections. Curr Orthop Pract 22(6): 558-563.
24. Bernthal NM, Stavrakis AI, Billi F, Cho JS, Kremen TJ, et al. (2010) A Mouse Model of Post-Arthroplasty Staphylococcus aureus Joint Infection to Evaluate In Vivo the Efficacy of Antimicrobial Implant Coatings. PLoS ONE 5(9): e12580 doi:10.1371/journal.pone.0012580.
25. Stepanovic S, Vukovic D, Dakic I, Savic B, Svabic-Vlahovic M, (2000) A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J. Microbiol. Methods 40: 175-179.
26. Petty W, Spanier S, Shuster JJ, Silverthorne C, (1985) The influence of skeletal implants on incidence of infection. Experiments in a canine model. J Bone Joint Surg Am 67: 1236-1244.
27. Pribaz JR, Bernthal NM, Billi F, Cho JS, Ramos RI, Guo Y, Cheung AL, Francis KP, Miller LS, (2012) Mouse model of chronic post-arthroplasty infection: non invasive in vivo bioluminescence imaging to monitor bacterial burden for long term study. J Orthop Res 30(3): 335-340.
28. Toms AD, Davidson D, Masri BA, Duncan CP, (2006) The management of peri-prosthetic infection in total joint arthroplasty. J Bone Joint Surg Br 88: 149-155.
29. Del Pozo JL, Patel R, (2009) Clinical practice. Infection associated with prosthetic joints. N Engl J Med 361: 787-794.
30. Lew DP, Waldvogel FA. 2004, Osteomyelitis. Lancet 364: 369-379.
31. Parvizi J, Zmistowski B, Adeli B, (2010) Periprosthetic joint infection: treatment options. Orthopedics 7; 33(9): 659.
32. Cierny G 3rd, Mader JT, Penninck JJ (2003) A clinical staging system for adult osteomyelitis. Clin Orthop Relat Res 414: 7-24.
33. Romanò CL, Romanò D, Logoluso N, Drago L (2011) Bone and joint infections in adults: a comprehensive classification proposal. Eur Orthop Traumatol 1: 207 -217; doi: 10.1007/s12570-011-0056-8.
34. Fujimura S, Sato T, Kikuchi T, Zaini J, Gomi K, Watanabe A, (2009) Efficacy of clarithromycin plus vancomycin in mice with implant-related infection caused by biofilm-forming Staphylococcus aureus. J Orthop Sci 14: 658-661.
35. Stewart S, Barr S, Engiles J, et al. (2012) Vancomycin-modified implant surface inhibits biofilm formation and support bone-healing in infected osteotomy model in sheep. J Bone Joint Surg Am 94: 1406-1415.
36. Dalton T, Dowd SE, Wolcott RD, et al. (2011) An in vivo polymicrobial biofilm wound infection model to study interspecies interactions,. PLoS ONE 6 (11): e27317.
37. Liu Z, Aronson J, Wahl E, et al. (2007) A novel rat model for the study of deficits in bone formation in type-2 diabetes. Acta Orthop 78: 46-55.
38. Funao H, Ishii K, Nagai S, Sasaki A et al. (2011) Establishment of a Real-time, Quantitative and Reproducible Mouse Model of Staphylococcal Osteomyelitis using Bioluminescence Imaging. Infect Immun doi:10.1128/IAI.06166-11.
39. Wu H, Haist V, Baumgärtner W, Schughart K, (2010) Sustained viral load and late death in Rag2-/-mice after influenza A virus infection. Virology Journal 7: 172.
40. Marhoffer W, Stein M, Schleinkofer L, Federlin K, (1993) Evidence of ex vivo and in vitro impaired neutrophil oxidative burst and phagocytic capacity in type 1 diabetes mellitus. Diabetes Res Clin Pract 19: 183-188.
41. Tater D, Tepaut B, Bercovici JP, Youinou P (1987) Polymorphonuclear cell derangements in type I diabetes. Horm Metab Res 19:642- 647.
42. Repine JE, Clawson CC, Goetz FC (1980) Bactericidal function of neutrophils from patients with acute bacterial infections and from diabetics. J Infect Dis 142:869-875, 1980.
43. Spatz M, Eibl N, Hink S, et al. (2003) Impaired primary immune response in type-1 diabetes. Functional impairment at the level of APCs and T-cells. Cell Immunol 221: 15-26.
44. Rubinstein R, Genaro AM, Motta A, Cremaschi G, Wald MR, (2008) Impaired immune responses in streptozotocin-induced type I diabetes inmice. Involvement of high glucose. Clin Exp Immunol 154: 235-246.
45. Veronelli A, Laneri M, Ranieri R, et al. (2004) White blood cells in obesity and diabetes: effects of weight loss and normalization of glucose metabolism. Diabetes Care 27: 2501-2502.
46. Tong PC, Lee KF, So WY, Ng MH, Chan WB, Lo MK, Chan NN, Chan JC, (2004) White blood cell count is associated with macro- and microvascular complications in Chinese patients with type 2 diabetes. Diabetes Care 27: 216-222.
47. Pettersson US, Christoffersson G, Massena S, Ahl D, Jansson L, et al. (2011) Increased Recruitment but Impaired Function of Leukocytes during Inflammation in Mouse Models of Type 1 and Type 2 Diabetes. PLoS ONE 6(7): e22480 doi:10.1371/journal.pone.0022480.
48. Teupser D, Weber O, Ro TN, Sass K, Thiery J, Fehling HJ, (2011) No reduction of atherosclerosis in C-reactive Protein (CRP)-deficient mice. J Biological Chemistry 286 (8): 6272-6279.
49. Butt WP, (1973) The radiology of infection. Clin Orthop Relat Res 96: 20-30.
50. Lankinen P, Lehtimäki K, Hakanen AJ, Roivainen A, Aro HT, (2012) A comparative 18F-FDG PET/CT imaging of experimental Staphylococcus aureus osteomyelitis and Staphylococcus epidermidis foreign-body-associated infection in the rabbit tibia. EJNMMI Research 2: 41.
51. Repine JE, Clawson CC, Goetz FC, (1980) Bactericidal function of neutrophils from patients with acute bacterial infections and from diabetics. J Infect Dis 142: 869-875.
52. Delamaire M, Maugendre D, Moreno M, Le Goff MC, Allannic H, Genetet B (1997) Impaired leukocyte functions in diabetic patients. Diabet Med 14: 29 -34.
53. Guglielmo BJ, Luber AD, Paletta D, Jacobs RA, (2000) Ceftriaxone Therapy for Staphylococcal Osteomyelitis: A Review. Clinical Infectious Diseases 30: 205-207.
54. Mazza A, (2000) Ceftriaxone as short-term antibiotic prophylaxis in orthopedic surgery: a cost-benefit analysis involving 808 patients. J Chemother 12(3): 29-33.
55. Alt V, Bitschnau A, Österling J, et al. (2006) The effects of combined gentamicin-hydroxyapatite coating for cementless joint prostheses on the reduction of infection rates in a rabbit infection prophylaxis model. Biomaterials 27: 4627-4634.
56. Kaya M, Kaya GS, Gürsan N, et al. (2012) Local treatment of chronic osteomyelitis with surgical debridement and tigecycline-impregnated calcium hydroxyapatite: an experimental study. Oral Surg Oral Med Oral Pathol Oral Radiol 113: 340-347.
57. Liu Y, Zheng Z, Zara JN, et al. (2012) The antimicrobial and osteoinductive properties of silver nanoparticles/poly (DL-lactic-co-glycolic acid)-coated stainless steel. Biomaterials 33: 8745-8756.
58. Maruyama T, Takei I, Yanagawa T, et al. (1988) Insulin autoantibodies in non-obese diabetic (NOD) mice and streptozotocin-induced diabetic mice. Diabetes Res 7(2): 93-6.
59. Facchiano F, Lentini A, Fogliano V, et al. (2002) Sugar-induced modification of fibroblast growth factor 2 reduces its angiogenic activity in vivo. Am J Pathol 161(2): 531-41.
60. Tersey SA, Nishiki Y, Templin AT, et al. (2012) Islet β-cell endoplasmic reticulum stress precedes the onset of type 1 diabetes in the nonobese diabetic mouse model. Diabetes 61(4): 818-27.